Advertisement

  • Survivor Profile

    Sharing Her Strength

    Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

    by Lindsey Konkel

  • Medicare Coverage for Next-Generation Sequencing Tests

    Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.

    by Ashley P. Taylor

  • BRCA: Who Should Be Tested?

    Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.

    by Sue Rochman

  • Our Own Words

    People with cancer and their loved ones find ways for their voices to be heard without filters.

    by Bradley Jones

  • Finding Support in Unlikely Places

    After her diagnosis with ovarian cancer, Patricia Anne Ward noticed that some friends and family pulled away. She found connection outside her usual circles.

    by Patricia Anne Ward

  • Advocacy Spotlight: Sorting Out Priorities

    Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions.

    by Cici Zhang

  • Forward Look

    Little Consensus on Ovarian Cancer Monitoring

    Tests and scans may be overused.

    by Kate Yandell

  • Survivor Profile

    Going Full Bore

    Susan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense.

    by Sue Rochman

  • Forward Look

    Identifying Ovarian Cancer Risk

    Study may help spotlight women who would benefit from risk reduction strategies.

    by Carrie Printz

  • Healthy Habits

    A Cup of Tea?

    Black tea consumption may be associated with a reduced risk of ovarian cancer.

    by Kurt Ullman

Advertisement
Advertisement

From the AACR

Advertisement

Video

Handle With Care

Advertisement

social media

donate to the AACR